Cingulate CING
NASDAQ CING
$5.20 -0.03 (-0.67%)
As of: Sep 22, 2026 · 10:24 AM EDT

Cingulate (CING) Non Operating Income (2021 - 2025)

Cingulate's (CING) quarterly Non Operating Income came in at -$573058.0 in Q3 2025, down 1235.15% on a YoY basis from $50483.0 in Q3 2024, and down 492.88% quarter-over-quarter from -$96656.0 in Q1 2025.

Analysis

Cingulate (CING) Non Operating Income (2021 - 2025) Analysis & Trends

Cingulate (CING) has reported Non Operating Income for 5 consecutive years, with -$573058.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 1235.15% year-over-year to -$573058.0; the trailing twelve-month figure through Sep 2025 stood at -$542721.0 (down 372.67% YoY), and the FY2024 full-year result was $99236.0, up 112.79% from the prior year.
  • Non Operating Income slipped to -$573058.0 in Q3 2025 per CING's latest filing, from -$96656.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $76510.0 in Q4 2024 and bottomed at -$573058.0 in Q3 2025.
  • Historically, Non Operating Income has averaged -$86195.2 across 5 years, with a median of -$17409.5 in 2021.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income soared 255.17% in 2022, then sank 3133.93% in 2023.
  • Over 5 years, Non Operating Income stood at -$6599.0 in 2021, then plunged by 1870.03% to -$130002.0 in 2022, then decreased by 5.8% to -$137546.0 in 2023, then jumped by 155.63% to $76510.0 in 2024, then plunged by 849.0% to -$573058.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$573058.0, -$96656.0, and $76510.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -139.24 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -573,058.00
Mar 31, 2025 -96,656.00
Dec 31, 2024 76,510.00
Sep 30, 2024 50,483.00
Jun 30, 2024 -3,497.00
Mar 31, 2024 -24,260.00
Dec 31, 2023 -137,546.00
Sep 30, 2023 -229,380.00
Jun 30, 2023 -253,940.00
Mar 31, 2023 -154,892.00
Dec 31, 2022 -130,002.00
Sep 30, 2022 -58,885.00
Jun 30, 2022 8,370.00
Mar 31, 2022 5,833.00
Dec 31, 2021 -6,599.00
Sep 30, 2021 -10,559.00
Jun 30, 2021 -9,676.00
Mar 31, 2021 -3,759.00
API Access

Cingulate Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CING&period=max&api_key=YOUR_API_KEY